Kabakoff David S - Jun 23, 2022 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in fact for David S. Kabakoff
Stock symbol
NXTC
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/24/2022, 05:21 PM
Previous filing
Jun 28, 2021
Next filing
Jun 23, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders.